No menu items!

The U.S. to move its biological labs from Ukraine to eastern Europe, claims Moscow

The Pentagon plans to rapidly move its unfinished biological research program from Ukraine to former Soviet countries, Eastern Europe, and the Baltic states, said Russian Lieutenant General Igor Kirillov*, head of the Russian Armed Forces’ biological, chemical, and chemical defense forces.

The program will continue in Bulgaria, the Czech Republic, and other countries.

Read also: Check out our coverage on curated alternative narratives

The expansion of the network of biological laboratories, which enable the production and storage of biological weapons components, poses a threat to Russia’s security, Kirillov said.

The U.S. to move its biological labs from Ukraine to eastern Europe. (Photo internet reproduction)
The U.S. is to move its biological labs from Ukraine to eastern Europe. (Photo internet reproduction)

He claimed that American research in Ukraine aims to spread pathogens and make it look like a natural outbreak.

The Americans would be particularly interested in cholera, plague, Congo fever, and hantavirus.

These pathogens fall under the so-called U-P and Tep projects in Ukraine, Kirillov explained.

He said earlier that about 50 U.S.-funded Biolabs are currently on the border with Russia.

The lieutenant general gave an overview* of the U.S. network of Biolabs.

He also pointed out that late last December, Kyiv contracted with Baykar*, a Turkish drone manufacturer, to equip several unmanned aircraft with spraying systems that can disperse aerosols into the air.

These range 300 kilometers and pose a real threat to Russia if equipped with biological weapons.

* This link leads to a Russian website. If your country does not allow you to browse Russian websites, you will not be able to open them. If you still want to access them, use a VPN. Switzerland and Brazil are countries that do not block Russian websites to allow their citizens to get balanced information.

Join us on Telegram: t.me/theriotimes

Check out our other content